October 24, 2017 / 9:25 PM / a month ago

BRIEF-Sanofi files suit in the U.S. to defend patent rights

Oct 24 (Reuters) - Sanofi SA

* Sanofi files suit in the U.S. to defend its patent rights on Lantus® and Lantus® Solostar®

* Sanofi - co ‍filed a patent infringement suit against Mylan​

* Sanofi - ‍suit triggered by notifications from Mylan stating that it had filed NDA with FDA for insulin glargine pre-filled pen and vial drug products​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below